These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1684 related items for PubMed ID: 10810803

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Effect of implantable cardioverter-defibrillator on left ventricular ejection fraction in patients with idiopathic dilated cardiomyopathy.
    Schaer B, Theuns DA, Sticherling C, Szili-Torok T, Osswald S, Jordaens L.
    Am J Cardiol; 2010 Dec 01; 106(11):1640-5. PubMed ID: 21094367
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Implantable cardioverter-defibrillator in patients with hypertrophic cardiomyopathy: efficacy and complications of the therapy in long-term follow-up.
    Syska P, Przybylski A, Chojnowska L, Lewandowski M, Sterliński M, Maciag A, Gepner K, Pytkowski M, Kowalik I, Maczyńska-Mazuruk R, Ruzyłło W, Szwed H.
    J Cardiovasc Electrophysiol; 2010 Aug 01; 21(8):883-9. PubMed ID: 20132378
    [Abstract] [Full Text] [Related]

  • 26. [The natural history of dilated cardiomyopathy: a review of the Heart Muscle Disease Registry of Trieste].
    Di Lenarda A, Pinamonti B, Mestroni L, Salvi A, Sabbadini G, Gregori D, Perkan A, Zecchin M, Carniel E, Bussani R, Silvestri F, Morgera T, Camerini F, Sinagra G, Gruppo di Studio sulle Malattie del Miocardio.
    Ital Heart J Suppl; 2004 Apr 01; 5(4):253-66. PubMed ID: 15346692
    [Abstract] [Full Text] [Related]

  • 27. Comparison of ventricular arrhythmia burden, therapeutic interventions, and survival, in patients < 75 and patients >or= 75 years of age treated with implantable cardioverter defibrillators.
    Ermis C, Zhu AX, Vanheel L, Sakaguchi RN, Lurie KG, Lu F, Benditt DG.
    Europace; 2007 May 01; 9(5):270-4. PubMed ID: 17371804
    [Abstract] [Full Text] [Related]

  • 28. Life expectancy gains and cost-effectiveness of implantable cardioverter/defibrillators for the primary prevention of sudden cardiac death in patients with hypertrophic cardiomyopathy.
    You JJ, Woo A, Ko DT, Cameron DA, Mihailovic A, Krahn M.
    Am Heart J; 2007 Nov 01; 154(5):899-907. PubMed ID: 17967596
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Efficacy of implantable cardioverter-defibrillators for the prevention of sudden death in patients with hypertrophic cardiomyopathy.
    Maron BJ, Shen WK, Link MS, Epstein AE, Almquist AK, Daubert JP, Bardy GH, Favale S, Rea RF, Boriani G, Estes NA, Spirito P.
    N Engl J Med; 2000 Feb 10; 342(6):365-73. PubMed ID: 10666426
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Prediction of appropriate defibrillator therapy in heart failure patients treated with cardiac resynchronization therapy.
    Soliman OI, Theuns DA, van Dalen BM, Vletter WB, Nemes A, Jordaens LJ, Balk AH, Ten Cate FJ, Geleijnse ML.
    Am J Cardiol; 2010 Jan 01; 105(1):105-11. PubMed ID: 20102900
    [Abstract] [Full Text] [Related]

  • 33. Enhanced detection of arrhythmia vulnerability using T wave alternans, left ventricular ejection fraction, and programmed ventricular stimulation: a prospective study in subjects with chronic ischemic heart disease.
    Rashba EJ, Osman AF, Macmurdy K, Kirk MM, Sarang SE, Peters RW, Shorofsky SR, Gold MR.
    J Cardiovasc Electrophysiol; 2004 Feb 01; 15(2):170-6. PubMed ID: 15028046
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. [Short-term and long-term outcome of left heart function after cardioverter defibrillator implantation].
    Takeichi K, Kasanuki H, Ohnishi S, Endoh Y, Hosoda S.
    J Cardiol; 1996 Nov 01; 28(5):277-86. PubMed ID: 8953401
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Prognostic role of post-infarction C-reactive protein in patients undergoing implantation of cardioverter-defibrillators: design of the C-reactive protein Assessment after Myocardial Infarction to GUide Implantation of DEfibrillator (CAMI GUIDE) study.
    Bellocci F, Biasucci LM, Gensini GF, Padeletti L, Raviele A, Santini M, Giubilato G, Landolina M, Biondi-Zoccai G, Raciti G, Sassara M, Castro A, Kheir A, Crea F.
    J Cardiovasc Med (Hagerstown); 2007 Apr 01; 8(4):293-9. PubMed ID: 17413310
    [Abstract] [Full Text] [Related]

  • 39. Arrhythmia risk stratification with regard to prophylactic implantable defibrillator therapy in patients with dilated cardiomyopathy. Results of MACAS, DEFINITE, and SCD-HeFT.
    Grimm W, Alter P, Maisch B.
    Herz; 2004 May 01; 29(3):348-52. PubMed ID: 15167963
    [Abstract] [Full Text] [Related]

  • 40. Predictors of appropriate defibrillator therapy among patients with an implantable defibrillator that delivers cardiac resynchronization therapy.
    Desai AD, Burke MC, Hong TE, Kim S, Salem Y, Yong PG, Knight BP.
    J Cardiovasc Electrophysiol; 2006 May 01; 17(5):486-90. PubMed ID: 16684019
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 85.